A few months after sending an untitled letter to ARS Pharmaceuticals, taking issue with certain aspects of a TV commercial about its epinephrine nasal spray, the FDA is reiterating its concerns about ...
Federal regulators are taking action against a Utah County-based nasal spray company, alleging that it falsely claimed its product could protect users against COVID-19. In magazine ads, online videos, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results